BCR-ABL-expressing CML cells accumulate specific defects in DNA repair pathways, including the downregulation of breast cancer gene (BRCA)1 and the DNA-dependent protein kinase (DNA-PK) catalytic subunit. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.